6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neurochemical Changes in Addiction Recovery
Addiction recovery is accompanied by significant neurochemical changes as the brain attempts to restore balance after prolonged substance use. Chronic addiction alters neurotransmitter systems, such as dopamine and serotonin, leading to impaired reward processing and emotional regulation. During recovery, these systems gradually adapt, although this process can take months or even years. Neuroplasticity plays a vital role in rebuilding neural pathways associated with decision-making and impulse control. Interventions like exercise, nutrition, and pharmacotherapy can accelerate neurochemical restoration. Understanding these changes helps tailor recovery programs to address withdrawal symptoms, cravings, and emotional instability, ultimately supporting long-term recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States